ArticleBMC genomics2025
First whole-genome sequence of Mycobacterium avium subsp. silvaticum isolated from a diseased Egyptian goose (Alopochen aegyptiaca).
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmong the non-tuberculous mycobacteria, Mycobacterium (M.) avium are important pathogens for humans and/or animals. Currently, there are four M. avium subspecies: subsp. hominissuis (Mah), subsp. paratuberculosis (Map), subsp. avium (Maa), and subsp. silvaticum (Mas). While sufficient data is available for the first three mentioned, only few reports exist on the isolation, epidemiology and even less on the genetic equipment of Mas.
resultsHere, Mas was isolated from an Egyptian goose that died of avian tuberculosis. Subspecies identification was based on the presence of IS901 and IS1245 as well as Mycobacterial Interspersed Repetitive Units-Variable Number Tandem Repeat analysis demonstrating Mas specific profile INMV99 profile. During cultural isolation, Mas showed preference for media with mycobactin supplementation but was not limited to mycobactin-containing media. A closed genome sequence was assembled using short- and long-read sequencing technology. The genome sequence consisted of one circular chromosome of 4.84 Mb (GC content 69.3%) and no plasmid. It was highly similar to the only other available Mas sequence (ANI 99.98%, GGDC 99.7%) and eight Maa sequences (ANI ≥99.88%, GGDC ≥98.9%), although all Maa genomes were larger (approx. 5 Mb). In silico prediction of the metabolic pathways and gene content found that all Maa but no Mas should be able to synthetize ergothioneine and the carotenoid neurosporene. The analysis of the mycobactin cluster mbt-1 made it obvious that in Mas two of the eleven mbt genes (mbtB and mbtE) were probably dysfunctional due frameshift-based disruptions.
conclusionsThe first complete, high quality, closed genome sequence of a Mas isolate closes a knowledge gap. Even if the collection of further genome sequences is considered necessary, the now existing data set already enables a deeper analysis of M. avium. The found differences in the Mas gene content compared to the closest relative Maa seem to be stable and independent of spatial (France, UK, Germany) and temporal (>40 years) differences on their isolation. These data thus call into question the demand for merging the two subspecies Maa and Mas into one, but further genome sequences from other Mas strains are needed to answer this question conclusively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.